Publication: 4120

Publication: 4120

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood Adv vol 8 (6) 1464-1468

Year:: 2024
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Meta-Analysis
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 13

Parents:: 3972
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Celegene (CALGB 50803), GSK (CALGB 50901 and 50904)
Grants:: U10CA180821, U10CA180882, UG1CA233339, UG1CA233247

Corr. Author:
Authors:: Sarah C. Rutherford Jun Yin Levi D. Pederson Kristie A. Blum Peter Martin Sin-Ho Jung Barbara Grant Cara Rosenbaum Bruce D. Cheson Nancy L. Bartlett Sumithra J. Mandrekar John P. Leonard

Networks:: CAPITAL, LAPS-IL057, LAPS-MN026, LAPS-MO011, LAPS-OH007, NY018

Study: Alliance-A151737
Multiple Studies, or Legacy Studies in Alliance Study:: Alliance-A051103, CALGB-50701, CALGB-50803, CALGB-50901, CALGB-50904
Phases:: N/A, 1, 2

Keywords:: Research Letter